Deguelin Impairs Cell Adhesion, Migration and Invasion of Human Lung Cancer Cells through the NF-B Signaling Pathways

YT Hsiao, MJ Fan, AC Huang, JC Lien… - The American Journal …, 2018 - World Scientific
Deguelin, a rotenoid, is isolated from a natural plant species, and has biological activities
including antitumor function. In the present study, we investigated the effect of deguelin on …

EGFR tyrosine kinase inhibitor therapy for lung cancer treatments and their clinical outcomes: A cohort study in Taiwan

CH Chung - Oncology Letters, 2019 - spandidos-publications.com
Malignant cancer is the top cause of mortality in Taiwan. In particular, the mortality rate of
with lung cancer reached 39.2/100,000 in 2017. Epidermal growth factor receptor tyrosine …

The effectiveness and safety of immune checkpoint inhibitors in non-small cell lung cancer patients with stage III/IV: a multicenter study

JC Hsu, PA Nguyen, YT Chen, SC Yang, CC Lin… - Frontiers in …, 2021 - frontiersin.org
Immune checkpoint inhibitors (ICIs) have been approved to treat patients with various
cancer types, including lung cancer, in many countries. This study aims to investigate the …

Treatment outcome comparisons of first‐line targeted therapy in patients with KRAS wild‐type metastatic colorectal cancer: A nationwide database study

YH Liang, KH Chen, YY Shao - Cancer Medicine, 2023 - Wiley Online Library
Background The first‐line systemic therapy for metastatic colorectal cancer (mCRC) is a
combination of one targeted therapy agent and a chemotherapy doublet. Whether …

Real-World Utilization of Target-and Immunotherapies for Lung Cancer: A Scoping Review of Studies Based on Routinely Collected Electronic Healthcare Data

A Spini, G Hyeraci, C Bartolini, S Donnini… - International Journal of …, 2021 - mdpi.com
Routinely collected electronic healthcare data (rcEHD) have a tremendous potential for
enriching pre-marketing evidence on target-and immunotherapies used to treat lung cancer …

Peniciketal A, A Novel Spiroketal Compound, Exerts Anticancer Effects by Inhibiting Cell Proliferation, Migration and Invasion of A549 Lung Cancer Cells

X Gao, Y Zhou, X Zheng, H Sun… - Anti-Cancer Agents …, 2018 - ingentaconnect.com
Background: Peniciketal A (Pe-A) is a spiroketal compound isolated from saline soil-derived
fungus Penicillium raistrickii. However, its role for biological processes has not been …

Long-term survival effect of the interval between postoperative chemotherapy and radiotherapy in patients with completely resected pathological n2 non-small-cell …

SM Lin, HY Ku, CY Hsu, CL Wang, GC Chang… - Cancers, 2021 - mdpi.com
Simple Summary In patients with completely resected stage III pN2 non-small cell lung
cancer (NSCLC), adjuvant chemotherapy of 4–6 cycles was recommended prior to post …

艾迪注射液辅助治疗晚期非小细胞肺癌的疗效观察.

荀培, 韩磊, 赵丽波, 张颖, 陆汉红… - … & Analysis of Drug …, 2016 - search.ebscohost.com
摘! 要! 目的: 观察艾迪注射液联合含铂方案化疗治疗晚期非小细胞肺癌的疗效,
探讨其减轻化疗不良反应的作用. 方法: 选取"# $" 年> 月&"# $ A 年> 月收治的$> C …

[HTML][HTML] A Phase IV efficacy study of formeta plus carboplatin as first-line treatment of advanced non-squamous, non-small cell lung cancer in iran: an affordable price …

A Khosravi, B Salimi, Z Esfahani-Monfared… - Asian Pacific Journal …, 2018 - ncbi.nlm.nih.gov
Background: This study performed to assess the efficacy and safety of Formeta (generic form
of Pemetrexed) plus Carboplatin as first-line chemotherapy in advanced stage, non …

[PDF][PDF] Lung Cancer: Brief Account of Advance and Traditional Treatments and Diagnosis

J Shaikh, P Bangal, R Pandhre - Arch Can Res, 2016 - researchgate.net
Lung cancer is an uncontrolled growth of lung cells that's lead to form a tumour. More than
20% of total cancer death is due to lung cancer. There are mainly two types of effective …